MAPK pathway alterations as a targetable vulnerability in bladder cancer.

被引：0
|
作者：
D'Andrea, Vincent
Bekele, Raie
Hanlon, Timothy
Zhou, Yuzhen
Chroneos, Rea
Stelter, Isabella
Mouw, Kent William
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
3282-3301-3439-2725; 261-265-9287; 281-318-9705-11350; 3282-206-4957-326-5009-5024-5026; 261-566-148; 6; 2; 166; 4344; 62; 3; 1; 38092-38288; 38092-30665; 38092-26655; 38092-28187; 38092-26692; 8; 4;
D O I：
10.1200/JCO.2024.42.4_suppl.672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
672
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [41] Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
    Nickerson, Michael L.
    Dancik, Garrett M.
    Im, Kate M.
    Edwards, Michael G.
    Turan, Sevilay
    Brown, Joseph
    Ruiz-Rodriguez, Christina
    Owens, Charles
    Costello, James C.
    Guo, Guangwu
    Tsang, Shirley X.
    Li, Yingrui
    Zhou, Quan
    Cai, Zhiming
    Moore, Lee E.
    Lucia, M. Scott
    Dean, Michael
    Theodorescu, Dan
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4935 - 4948
  • [42] KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway in breast cancer.
    Jia, Yunlu
    Wang Linbo
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 48 - 48
  • [43] TARGETED THERAPY FOR MAPK PATHWAY ALTERATIONS IN PEDIATRIC TUMORS
    Suthar, Jugal
    Taylor, Alaric
    Berry, Philip
    Veal, Gareth
    Guldin, Stefan
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S619 - S620
  • [44] Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Reis, Henning
    van der Vos, Kristan E.
    Niedworok, Christian
    Herold, Thomas
    Modos, Orsolya
    Szendroi, Attila
    Hager, Thomas
    Ingenwerth, Marc
    Vis, Daniel J.
    Behrendt, Mark A.
    de Jong, Jeroen
    van der Heijden, Michiel S.
    Peyronnet, Benoit
    Mathieu, Romain
    Wiesweg, Marcel
    Ablat, Jason
    Okon, Krzysztof
    Tolkach, Yuri
    Bremmer, Felix
    Gaisa, Nadine T.
    Chlosta, Piotr
    Kriegsmann, Joerg
    Timar, Jozsef
    Kristiansen, Glen
    Radzun, Heinz-Joachim
    Knuechel, Ruth
    Schuler, Martin
    Black, Peter C.
    Ruebben, Herbert
    Hadaschik, Boris
    Schmid, Kurt Werner
    van Rhijn, Bas W.
    Nyirady, Peter
    Szarvas, Tibor
    MODERN PATHOLOGY, 2018, 31 : 378 - 378
  • [45] Comprehensive analysis of targetable alterations in urachal cancer by NGS.
    Benjamin, David Joseph
    Adeyelu, Tolulope Tosin
    Elliott, Andrew
    Darabi, Sourat
    Lee, Thomas
    McKay, Rana R.
    Oberley, Matthew James
    Rezazadeh, Arash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 663 - 663
  • [46] Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations
    Garcia, Joseph H.
    Akins, Erin A.
    Jain, Saket
    Wolf, Kayla J.
    Zhang, Jason
    Choudhary, Nikita
    Lad, Meeki
    Shukla, Poojan
    Rios, Jennifer
    Seo, Kyounghee
    Gill, Sabraj A.
    Carson, William H.
    Carette, Luis R.
    Zheng, Allison C.
    Raleigh, David R.
    Kumar, Sanjay
    Aghi, Manish K.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [47] Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Reis, Henning
    van der Vos, Kristan E.
    Niedworok, Christian
    Herold, Thomas
    Modos, Orsolya
    Szendroi, Attila
    Hager, Thomas
    Ingenwerth, Marc
    Vis, Daniel J.
    Behrendt, Mark A.
    De Jong, Jeroen
    van der Heijden, Michiel S.
    Peyronnet, Benoit
    Mathieu, Romain
    Wiesweg, Marcel
    Ablat, Jason
    Okon, Krzysztof
    Tolkach, Yuri
    Bremmer, Felix
    Gaisa, Nadine T.
    Chlosta, Piotr
    Kriegsmann, Joerg
    Timar, Jozsef
    Kristiansen, Glen
    Radzun, Heinz-Joachim
    Knuechel, Ruth
    Schuler, Martin
    Black, Peter C.
    Ruebben, Herbert
    Hadaschik, Boris
    Schmid, Kurt Werner
    van Rhijn, Bas W.
    Nyirady, Peter
    Szarvas, Tibor
    LABORATORY INVESTIGATION, 2018, 98 : 378 - 378
  • [48] Epigenetic Alterations in Bladder Cancer
    Sima P. Porten
    Current Urology Reports, 2018, 19
  • [49] Molecular alterations in bladder cancer
    Cordon-Cardo, C
    CANCER SURVEYS, 1998, 32 : 115 - 131
  • [50] Molecular alterations in bladder cancer
    Orntoft, TF
    Wolf, H
    UROLOGICAL RESEARCH, 1998, 26 (04): : 223 - 233
12345